Hrt Financial LP Cue Biopharma, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.24 - $2.18 $65,506 - $115,165	52,828 New	52,828 $65,000
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $261,121 - $620,818	-104,868 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.41 - $12.28 $462,467 - $1.29 Million	104,868 New	104,868 $511,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $295,272 - $485,323	-27,189 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.06 - $15.3 $273,521 - $415,991	27,189 New	27,189 $396,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $39.3M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.